Munich, Germany

Wolfgang Burk

This inventor holds 1 USPTO granted patent. Top assignee: Behringwerke Aktiengesellschaft. Active years: 1987.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wolfgang Burk. Retrieved from https://idiyas.com/inventor/wolfgang-burk-bpj6fsiz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 104(Granted Patents)


Company Filing History:


Years Active: 1987

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Wolfgang Burk: Innovator in Fibrinogen Formulation

Introduction

Wolfgang Burk is a notable inventor based in Munich, Germany. He has made significant contributions to the field of medical formulations, particularly in the development of fibrinogen solutions. His innovative work has implications for both human and animal tissue applications.

Latest Patents

Wolfgang Burk holds a patent for a readily dissolvable lyophilized fibrinogen formulation. This solid fibrinogen formulation contains, in addition to fibrinogen, a substance containing the urea or guanidine radical. The process for its preparation is also described in the patent. This formulation is particularly useful for preparing a fibrinogen solution that serves as an adhesive for human and animal tissue, as well as a fibrinogen concentrate for intravenous administration. He has 1 patent to his name.

Career Highlights

Wolfgang Burk is associated with Behringwerke Aktiengesellschaft, a company known for its advancements in biopharmaceuticals. His work at this organization has allowed him to focus on innovative solutions that enhance medical treatments.

Collaborations

Wolfgang has collaborated with notable colleagues such as Peter Fuhge and Norbert Heimburger. Their combined expertise has contributed to the success of various projects within the company.

Conclusion

Wolfgang Burk's contributions to fibrinogen formulation represent a significant advancement in medical technology. His innovative approach continues to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…